Showing results (1241-1250 of 6,326) with videos related to
Sort By:
Pageof 633
Diabetes, Obesity & Metabolism|March 27, 2024
TAAR1 agonist ulotaront delays gastric emptying of solids in patients with schizophrenia and concurrent metabolic syndrome with prediabetesSnežana Milanović, Nina Dedic, Robert Lew, et al.Diabetes, Obesity & Metabolism|March 26, 2024
Comparison of estimated glomerular filtration rate change with sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists among people with diabetes: A propensity-score matching studyYuta Suzuki, Hidehiro Kaneko, Hajime Nagasawa, et al.Diabetes, Obesity & Metabolism|April 1, 2024
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label studyElena A Christofides, Orlando Puente, Paul Norwood, et al.Diabetes, Obesity & Metabolism|April 1, 2024
Effect of combination pioglitazone with sodium-glucose cotransporter-2 inhibitors or glucagon-like peptide-1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta-analysis, and real-world study from an international federated databaseMatthew Anson, Alex E Henney, Sizheng S Zhao, et al.Diabetes, Obesity & Metabolism|April 1, 2024
Short, frequent, light-intensity walking activity improves postprandial vascular-inflammatory biomarkers in people with type 1 diabetes: The SIT-LESS randomized controlled trialNawaz Z Safdar, Anwar M Alobaid, Mark Hopkins, et al.Diabetes, Obesity & Metabolism|April 1, 2024
An update review of post-transplant diabetes mellitus: Concept, risk factors, clinical implications and managementMehmet Kanbay, Sidar Copur, A Umur Topçu, et al.Diabetes, Obesity & Metabolism|March 20, 2024
The effect of bolus advisors on glycaemic parameters in adults with diabetes on intensive insulin therapy: A systematic review with meta-analysisElisabeth J den Brok, Cecilie H Svensson, Maria Panagiotou, et al.Diabetes, Obesity & Metabolism|September 13, 2023
Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trialEmily R Hankosky, Hui Wang, Lisa M Neff, et al.Diabetes, Obesity & Metabolism|September 11, 2023
Association between weight loss and health care resource utilization in adults living with obesity: Evidence from a UK primary care databaseChris Bojke, Silvia Capucci, Christiane Lundegaard Haase, et al.Diabetes, Obesity & Metabolism|September 5, 2023
Younger patients and low c-peptide immunoreactivity index but not nutritional states affect fasting blood ketone levels in Japanese with type 1 diabetes after sodium-glucose cotransporter 2 inhibitor administrationHanako Nakajima, Hiroshi Okada, Yuta Yoshimura, et al.Pageof 633